Article Excerpt: Results of the first clinical trial of an AI-generative therapy chatbot showed “significant, clinically meaningful reductions in depression, anxiety, and eating disorder symptoms” within four to eight weeks, said lead study author Michael V. Heinz, MD, a professor at Dartmouth College’s Geisel School of Medicine and faculty affiliate at the Center for Technology and Behavioral Health in Lebanon, New Hampshire.
The chatbot — Therabot, developed at Dartmouth — combines extensive training in evidence-based psychotherapy interventions with advanced generative AI. “We saw high levels of user engagement — six-plus hours on average across the study,” Heinz said. Participants said using Therabot was like talking to a human therapist. But results are early, and more studies are needed, Heinz said.
Full Article: https://tinyurl.com/sb3e2amw
Article Source: WebMD